Osteocrin, a peptide secreted from the heart and other tissues, contributes to cranial osteogenesis and chondrogenesis in zebrafish

Development (Cambridge)

Volumn 144, Issue 2, 2017, Pages 334-344

  Chiba, Ayano ^a   Watanabe Takano, Haruko ^a   Terai, Kenta ^b   Fukui, Hajime ^a   Miyazaki, Takahiro ^a   Uemura, Mami ^b   Hashimoto, Hisashi ^c   Hibi, Masahiko ^c   Fukuhara, Shigetomo ^d   Mochizuki, Naoki ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

^d NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Chondrogenesis; Heart; Nppa; Nppb; Nppc; Osteocrin; Osteogenesis; Peptide

Indexed keywords

BRAIN PEPTIDE; CYCLIC GMP DEPENDENT PROTEIN KINASE; OSTEOCRIN; PEPTIDE HORMONE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR WWTR1; TRANSCRIPTION FACTOR YAP1; UNCLASSIFIED DRUG; OSTEOCRIN, ZEBRAFISH; ZEBRAFISH PROTEIN;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CHONDROGENESIS; CONTROLLED STUDY; EMBRYO; GENE OVEREXPRESSION; HEART TISSUE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN SECRETION; SKULL DEVELOPMENT; ZEBRA FISH; ANIMAL; ANIMAL STRUCTURES; CARDIAC MUSCLE CELL; CELL CULTURE; DRUG EFFECTS; EMBRYOLOGY; GENETICS; HEART; HEK293 CELL LINE; HUMAN; METABOLISM; MOUSE; NONMAMMALIAN EMBRYO; ORGANOGENESIS; PHYSIOLOGY; SECRETION (PROCESS); SKULL; TRANSGENIC ANIMAL;

ANIMAL STRUCTURES; ANIMALS; ANIMALS, GENETICALLY MODIFIED; CELLS, CULTURED; CHONDROGENESIS; EMBRYO, NONMAMMALIAN; HEART; HEK293 CELLS; HUMANS; MICE; MYOCYTES, CARDIAC; ORGANOGENESIS; OSTEOGENESIS; PEPTIDE HORMONES; SKULL; TRANSCRIPTION FACTORS; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 85010040214     PISSN: 09501991     EISSN: 14779129     Source Type: Journal    
DOI: 10.1242/dev.143354     Document Type: Article

References (55)

1. Arita, Y., Nakaoka, Y., Matsunaga, T., Kidoya, H., Yamamizu, K., Arima, Y., Kataoka-Hashimoto, T., Ikeoka, K., Yasui, T., Masaki, T. et al. (2014). Myocardium-derived angiopoietin-1 is essential for coronary vein formation in the developing heart. Nat. Commun. 5, 4552.
2. Asakawa, K., Suster, M. L., Mizusawa, K., Nagayoshi, S., Kotani, T., Urasaki, A., Kishimoto, Y., Hibi, M. and Kawakami, K. (2008). Genetic dissection of neural circuits by Tol2 transposon-mediated Gal4 gene and enhancer trapping in zebrafish. Proc. Natl. Acad. Sci. USA 105, 1255-1260.
3. Becker, J. R., Chatterjee, S., Robinson, T. Y., Bennett, J. S., Panakova, D., Galindo, C. L., Zhong, L., Shin, J. T., Coy, S. M., Kelly, A. E. et al. (2014). Differential activation of natriuretic peptide receptors modulates cardiomyocyte proliferation during development. Development 141, 335-345.
4. Byun, M. R., Kim, A. R., Hwang, J.-H., Kim, K. M., Hwang, E. S. and Hong, J.-H. (2014). FGF2 stimulates osteogenic differentiation through ERK induced TAZ expression. Bone 58, 72-80.
5. Dauphinee, S. M., Eva, M. M., Yuki, K. E., Herman, M., Vidal, S. M. and Malo, D. (2013). Characterization of two ENU-induced mutations affecting mouse skeletal morphology. G3 (Bethesda) 3, 1753-1758.
6. Deng, Y., Wu, A., Li, P., Li, G., Qin, L., Song, H. and Mak, K. K. (2016). Yap1 regulates multiple steps of chondrocyte differentiation during skeletal development and bone repair. Cell Rep. 14, 2224-2237.
7. Eda, H., Aoki, K., Marumo, K., Fujii, K. and Ohkawa, K. (2008). FGF-2 signaling induces downregulation of TAZ protein in osteoblastic MC3T3-E1 cells. Biochem. Biophys. Res. Commun. 366, 471-475.
8. Hagiwara, H., Sakaguchi, H., Itakura, M., Yoshimoto, T., Furuya, M., Tanaka, S. and Hirose, S. (1994). Autocrine regulation of rat chondrocyte proliferation by natriuretic peptide C and its receptor, natriuretic peptide receptor-B. J. Biol. Chem. 269, 10729-10733.
9. Hong, J.-H., Hwang, E. S., McManus, M. T., Amsterdam, A., Tian, Y., Kalmukova, R., Mueller, E., Benjamin, T., Spiegelman, B. M., Sharp, P. A. et al. (2005). TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 309, 1074-1078.
10. Iglesias-Bartolome, R., Torres, D., Marone, R., Feng, X., Martin, D., Simaan, M., Chen, M., Weinstein, L. S., Taylor, S. S., Molinolo, A. A. et al. (2015). Inactivation of a Galpha(s)-PKA tumour suppressor pathway in skin stem cells initiates basal-cell carcinogenesis. Nat. Cell Biol. 17, 793-803.
11. Ivkovic, S., Yoon, B. S., Popoff, S. N., Safadi, F. F., Libuda, D. E., Stephenson, R. C., Daluiski, A. and Lyons, K. M. (2003). Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 130, 2779-2791.
12. Jaubert, J., Jaubert, F., Martin, N., Washburn, L. L., Lee, B. K., Eicher, E. M. and Guenet, J.-L. (1999). Three new allelic mouse mutations that cause skeletal overgrowth involve the natriuretic peptide receptor C gene (Npr3). Proc. Natl. Acad. Sci. USA 96, 10278-10283.
13. Kake, T., Kitamura, H., Adachi, Y., Yoshioka, T., Watanabe, T., Matsushita, H., Fujii, T., Kondo, E., Tachibe, T., Kawase, Y. et al. (2009). Chronically elevated plasma C-type natriuretic peptide level stimulates skeletal growth in transgenic mice. Am. J. Physiol. Endocrinol. Metab. 297, E1339-E1348.
14. Karsenty, G., Kronenberg, H. M. and Settembre, C. (2009). Genetic control of bone formation. Annu. Rev. Cell Dev. Biol. 25, 629-648.
15. Kashiwada, T., Fukuhara, S., Terai, K., Tanaka, T., Wakayama, Y., Ando, K., Nakajima, H., Fukui, H., Yuge, S., Saito, Y. et al. (2015). Beta-Catenindependent transcription is central to Bmp-mediated formation of venous vessels. Development 142, 497-509.
16. Kim, M., Kim, M., Lee, S., Kuninaka, S., Saya, H., Lee, H., Lee, S. and Lim, D.-S. (2013). cAMP/PKA signalling reinforces the LATS-YAP pathway to fully suppress YAP in response to actin cytoskeletal changes. EMBO J. 32, 1543-1555.
17. Kimmel, C. B., Ballard, W. W., Kimmel, S. R., Ullmann, B. and Schilling, T. F. (1995). Stages of embryonic development of the zebrafish. Dev. Dyn. 203, 253-310.
18. Knopf, F., Hammond, C., Chekuru, A., Kurth, T., Hans, S., Weber, C. W., Mahatma, G., Fisher, S., Brand, M., Schulte-Merker, S. et al. (2011). Bone regenerates via dedifferentiation of osteoblasts in the zebrafish fin. Dev. Cell 20, 713-724.
19. Komatsu, Y., Chusho, H., Tamura, N., Yasoda, A., Miyazawa, T., Suda, M., Miura, M., Ogawa, Y. and Nakao, K. (2002). Significance of C-type natriuretic peptide (CNP) in endochondral ossification: analysis of CNP knockout mice. J. Bone Miner. Metab. 20, 331-336.
20. Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R. T., Gao, Y.-H., Inada, M. et al. (1997). Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755-764.
21. Li, N., Felber, K., Elks, P., Croucher, P. and Roehl, H. H. (2009). Tracking gene expression during zebrafish osteoblast differentiation. Dev. Dyn. 238, 459-466.
22. Lin, C.-H., Su, C.-H. and Hwang, P.-P. (2014). Calcium-sensing receptor mediates Ca(2+) homeostasis by modulating expression of PTH and stanniocalcin. Endocrinology 155, 56-67.
23. Long, F. and Ornitz, D. M. (2013). Development of the endochondral skeleton. Cold Spring Harb. Perspect. Biol. 5, a008334.
24. Matsukawa, N., Grzesik, W. J., Takahashi, N., Pandey, K. N., Pang, S., Yamauchi, M. and Smithies, O. (1999). The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc. Natl. Acad. Sci. USA 96, 7403-7408.
25. Moffatt, P. and Thomas, G. P. (2009). Osteocrin–beyond just another bone protein? Cell Mol. Life Sci. 66, 1135-1139.
26. Moffatt, P., Thomas, G., Sellin, K., Bessette, M.-C., Lafreniere, F., Akhouayri, O., St-Arnaud, R. and Lanctot, C. (2007). Osteocrin is a specific ligand of the natriuretic Peptide clearance receptor that modulates bone growth. J. Biol. Chem. 282, 36454-36462.
27. Mundy, C., Gannon, M. and Popoff, S. N. (2014). Connective tissue growth factor (CTGF/CCN2) negatively regulates BMP-2 induced osteoblast differentiation and signaling. J. Cell Physiol. 229, 672-681.
28. Nishizawa, H., Matsuda, M., Yamada, Y., Kawai, K., Suzuki, E., Makishima, M., Kitamura, T. and Shimomura, I. (2004). Musclin, a novel skeletal muscle-derived secretory factor. J. Biol. Chem. 279, 19391-19395.
29. Ogawa, T. and de Bold, A. J. (2014). The heart as an endocrine organ. Endocr. Connect. 3, R31-R44.
30. Potter, L. R., Abbey-Hosch, S. and Dickey, D. M. (2006). Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr. Rev. 27, 47-72.
31. Riley, P. R. and Smart, N. (2011). Vascularizing the heart. Cardiovasc. Res. 91, 260-268.
32. Schilling, T. F. and Kimmel, C. B. (1997). Musculoskeletal patterning in the pharyngeal segments of the zebrafish embryo. Development 124, 2945-2960.
33. Smerdel-Ramoya, A., Zanotti, S., Stadmeyer, L., Durant, D. and Canalis, E. (2008). Skeletal overexpression of connective tissue growth factor impairs bone formation and causes osteopenia. Endocrinology 149, 4374-4381.
34. Soltanoff, C. S., Yang, S., Chen, W. and Li, Y.-P. (2009). Signaling networks that control the lineage commitment and differentiation of bone cells. Crit. Rev. Eukaryot. Gene Expr. 19, 1-46.
35. Spoorendonk, K. M., Peterson-Maduro, J., Renn, J., Trowe, T., Kranenbarg, S., Winkler, C. and Schulte-Merker, S. (2008). Retinoic acid and Cyp26b1 are critical regulators of osteogenesis in the axial skeleton. Development 135, 3765-3774.
36. Stepan, H., Leitner, E., Siems, W.-E., Maul, B. and Walther, T. (1999). mRNA quantification of C-type natriuretic peptide in brain areas of rodents. Peptides 20, 1243-1245.
37. Stepan, H., Faber, R., Stegemann, S., Schultheiss, H.-P. and Walther, T. (2002). Expression of C-type natriuretic peptide in human placenta and myometrium in normal pregnancies and pregnancies complicated by intrauterine growth retardation. Preliminary results. Fetal Diagn. Ther. 17, 37-41.
38. Subbotina, E., Sierra, A., Zhu, Z., Gao, Z., Koganti, S. R. K., Reyes, S., Stepniak, E., Walsh, S. A., Acevedo, M. R., Perez-Terzic, C. M. et al. (2015). Musclin is an activity-stimulated myokine that enhances physical endurance. Proc. Natl. Acad. Sci. USA 112, 16042-16047.
39. Suda, M., Tanaka, K., Fukushima, M., Natsui, K., Yasoda, A., Komatsu, Y., Ogawa, Y., Itoh, H. and Nakao, K. (1996). C-type natriuretic peptide as an autocrine/paracrine regulator of osteoblast. Evidence for possible presence of bone natriuretic peptide system. Biochem. Biophys. Res. Commun. 223, 1-6.
40. Suda, M., Ogawa, Y., Tanaka, K., Tamura, N., Yasoda, A., Takigawa, T., Uehira, M., Nishimoto, H., Itoh, H., Saito, Y. et al. (1998). Skeletal overgrowth in transgenic mice that overexpress brain natriuretic peptide. Proc. Natl. Acad. Sci. USA 95, 2337-2342.
41. Tamura, N., Doolittle, L. K., Hammer, R. E., Shelton, J. M., Richardson, J. A. and Garbers, D. L. (2004). Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs. Proc. Natl. Acad. Sci. USA 101, 17300-17305.
42. Thomas, G., Moffatt, P., Salois, P., Gaumond, M.-H., Gingras, R., Godin, E., Miao, D., Goltzman, D. and Lanctot, C. (2003). Osteocrin, a novel bone-specific secreted protein that modulates the osteoblast phenotype. J. Biol. Chem. 278, 50563-50571.
43. Tseng, D.-Y., Chou, M.-Y., Tseng, Y.-C., Hsiao, C.-D., Huang, C.-J., Kaneko, T. and Hwang, P.-P. (2009). Effects of stanniocalcin 1 on calciumuptake in zebrafish (Danio rerio) embryo. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296, R549-R557.
44. Varelas, X. (2014). The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease. Development 141, 1614-1626.
45. Verreijdt, L., Debiais-Thibaud, M., Borday-Birraux, V., Van der Heyden, C., Sire, J.-Y. and Huysseune, A. (2006). Expression of the dlx gene family during formation of the cranial bones in the zebrafish (Danio rerio): differential involvement in the visceral skeleton and braincase. Dev. Dyn. 235, 1371-1389.
46. von, G. A., Lin, Z., Schlegelmilch, K., Honor, L. B., Pan, G. M., Buck, J. N., Ma, Q., Ishiwata, T., Zhou, B., Camargo, F. D. et al. (2012). YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy. Proc. Natl. Acad. Sci. USA 109, 2394-2399.
47. Westerfield, M. (2007). The Zebrafish Book. A Guide for the Laboratory Used of Zebrafsih (Danio rerio), 5th edn. Eugene, USA: University of Oregon Press.
48. Yang, J.-Y., Cho, S.W., An, J. H., Jung, J. Y., Kim, S.W., Kim, S. Y., Kim, J. E. and Shin, C. S. (2013). Osteoblast-targeted overexpression of TAZ increases bone mass in vivo. PLoS ONE 8, e56585.
49. Yasoda, A., Komatsu, Y., Chusho, H., Miyazawa, T., Ozasa, A., Miura, M., Kurihara, T., Rogi, T., Tanaka, S., Suda, M. et al. (2004). Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway. Nat. Med. 10, 80-86.
50. Zaidi, S. K., Sullivan, A. J., Medina, R., Ito, Y., vanWijnen, A. J., Stein, J. L., Lian, J. B. and Stein, G. S. (2004). Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription. EMBO J. 23, 790-799.
51. Zhang, H., Liu, C.-Y., Zha, Z.-Y., Zhao, B., Yao, J., Zhao, S., Xiong, Y., Lei, Q.-Y. and Guan, K.-L. (2009). TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition. J. Biol. Chem. 284, 13355-13362.
52. Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L. et al. (2007). Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 21, 2747-2761.
53. Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M. et al. (2008). TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 22, 1962-1971.
54. Zhao, B., Li, L., Lei, Q. and Guan, K. L. (2010). The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev. 24, 862-874.
55. Zhou, X., Zhang, Z., Feng, J. Q., Dusevich, V. M., Sinha, K., Zhang, H., Darnay, B. G. and de Crombrugghe, B. (2010). Multiple functions of Osterix are required for bone growth and homeostasis in postnatal mice. Proc. Natl. Acad. Sci. USA 107, 12919-12924.